We are live on ! Find out more
PR

Payden & Rygel Portfolio holdings

AUM $1.3B
1-Year Est. Return 28.32%
This Fund
S&P 500
This Quarter Est. Return
+11.06%
1 Year Est. Return
+28.32%
3 Year Est. Return
+89.13%
5 Year Est. Return
+123.15%
10 Year Est. Return
+353.66%
AUM
$2.16B
AUM Growth
+$235M
Cap. Flow
+$56.3M
Cap. Flow %
2.6%
Top 10 Hldgs %
21.21%
Holding
143
New
16
Increased
30
Reduced
43
Closed
17

Top Buys

Rank Stock Value
1
ETN icon
Eaton
ETN
+$35.7M
2
HYG icon
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
+$33.4M
3
AMT icon
American Tower
AMT
+$33M
4
ENB icon
Enbridge
ENB
+$26.4M
5
ADI icon
Analog Devices
ADI
+$26.4M

Top Sells

Rank Stock Value
1
MRK icon
Merck
MRK
+$38M
2
WMT icon
Walmart Inc
WMT
+$27.7M
3
ELV icon
Elevance Health
ELV
+$26.6M
4
CMCSA icon
Comcast
CMCSA
+$26.4M
5
TJX icon
TJX Companies
TJX
+$21.2M

Sector Composition

Rank Sector Weight
1 Financials 19.6%
2 Healthcare 17.19%
3 Technology 10.62%
4 Real Estate 9.3%
5 Consumer Staples 9.23%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CVS icon
1
CVS Health
CVS
$137B
$52.9M 2.44%
512,379
-2,200
-0.4% -$203K
MSFT icon
2
Microsoft
MSFT
$2.84T
$52.5M 2.43%
156,030
+57,200
+58% +$18.5M
ABBV icon
3
AbbVie
ABBV
$458B
$47.4M 2.19%
350,410
+69,460
+25% +$8.2M
JPM icon
4
JPMorgan Chase
JPM
$939B
$46M 2.13%
290,656
+1,600
+0.6% +$263K
BMY icon
5
Bristol-Myers Squibb
BMY
$127B
$45M 2.08%
721,960
+5,800
+0.8% +$340K
GS icon
6
Goldman Sachs
GS
$313B
$44.3M 2.05%
115,910
-600
-0.5% -$238K
PLD icon
7
Prologis
PLD
$138B
$43.6M 2.02%
259,100
+29,100
+13% +$4.34M
MS icon
8
Morgan Stanley
MS
$337B
$43.4M 2.01%
442,600
-2,400
-0.5% -$239K
SPY icon
9
State Street SPDR S&P 500 ETF Trust
SPY
$778B
$42.6M 1.97%
89,778
+7,470
+9% +$3.43M
LLY icon
10
Eli Lilly
LLY
$1.07T
$40.9M 1.89%
147,925
-1,800
-1% -$456K
UNP icon
11
Union Pacific
UNP
$183B
$39.8M 1.84%
158,030
+46,900
+42% +$11.1M
BAC icon
12
Bank of America
BAC
$435B
$39.5M 1.83%
888,390
-37,800
-4% -$1.72M
ABT icon
13
Abbott
ABT
$180B
$39.4M 1.82%
279,730
-900
-0.3% -$115K
TGT icon
14
Target
TGT
$62.1B
$38.3M 1.77%
165,500
+73,200
+79% +$17.8M
V icon
15
Visa
V
$677B
$38M 1.76%
175,200
-800
-0.5% -$172K
NEE icon
16
NextEra Energy
NEE
$187B
$37.4M 1.73%
400,600
-10,600
-3% -$916K
ETN icon
17
Eaton
ETN
$157B
$37.2M 1.72%
+215,130
New +$35.7M
PEP icon
18
PepsiCo
PEP
$186B
$36.9M 1.71%
212,700
-1,200
-0.6% -$196K
KO icon
19
Coca-Cola
KO
$354B
$36.6M 1.69%
618,380
-890
-0.1% -$49.6K
AMT icon
20
American Tower
AMT
$77.7B
$35.4M 1.63%
+120,860
New +$33M
EMB icon
21
iShares JPMorgan USD Emerging Markets Bond ETF
EMB
$14.9B
$35.3M 1.63%
323,800
+203,800
+170% +$22.2M
WMB icon
22
Williams Companies
WMB
$90.5B
$35.1M 1.62%
1,348,670
+11,100
+0.8% +$307K
MCD icon
23
McDonald's
MCD
$188B
$35.1M 1.62%
130,820
+26,800
+26% +$6.77M
HYG icon
24
iShares iBoxx $ High Yield Corporate Bond ETF
HYG
$16.3B
$33.5M 1.55%
+385,000
New +$33.4M
PAYX icon
25
Paychex
PAYX
$40.4B
$31.7M 1.46%
232,030
– –
1
2 3 4 5

Similar funds

GPCM
Greenbrier Partners Capital Management Dallas, Texas $1.3B AUM 21.43% 1-Year Est. Return
PWP
Private Wealth Partners Mill Valley, California $1.3B AUM 26.2% 1-Year Est. Return
MCM
Mainstay Capital Management Grand Blanc, Michigan $1.3B AUM 37.8% 1-Year Est. Return
SPC
Silver Point Capital Greenwich, Connecticut $1.3B AUM 18.3% 1-Year Est. Return
HCS
Himension Capital (Singapore) Singapore $1.3B AUM 85.53% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
SP
Sherman Porfolios Coeur D'alene, Idaho $1.3B AUM 35.18% 1-Year Est. Return
CCFM
Clear Creek Financial Management Silverdale, Washington $1.3B AUM 20.31% 1-Year Est. Return

Payden & Rygel's Q4 2021 Portfolio in Review

As of Q4 2021, Payden & Rygel held 143 positions worth $2.16B, up 12% from $1.93B the previous quarter. Its ten largest holdings account for 21% of the portfolio.

Payden & Rygel's Q4 2021 filing shows 16 new, 30 increased, 43 reduced and 17 closed positions. Its largest new stake was Eaton: 215,130 shares worth $37.2M. The largest sale was Merck, an estimated $38M.

By sector, the portfolio is most concentrated in Financials at 20% of assets, down from 20% a quarter earlier, followed by Healthcare and Technology.

  • Payden & Rygel's largest Q4 2021 buy was Eaton: 215,130 shares worth $37.2M.
  • Payden & Rygel added most to iShares JPMorgan USD Emerging Markets Bond ETF in Q4 2021, an estimated $22.2M increase.
  • Payden & Rygel's biggest Q4 2021 reduction was Merck, cutting an estimated $38M.
  • Payden & Rygel fully exited TJX Companies in Q4 2021, selling an estimated $21.2M.
  • Payden & Rygel's ten largest holdings make up 21% of its $2.16B portfolio in Q4 2021.
  • Payden & Rygel opened 16 new positions and closed 17 in Q4 2021.
  • Payden & Rygel's portfolio value rose 12% quarter-over-quarter to $2.16B.

Based on Payden & Rygel's 13F filing for Q4 2021, filed 11 Feb 2022.